Are you interested in more information about Mutaflor, our microbial drug containing the Escherichia coli strain Nissle 1917?
It is the first probiotic drug for which - aside from safety and tolerance - efficacy in maintaining remission of ulcerative colitis was proven by a confirmative clinical study as one of three all positive double-blind clinical trials on ulcerative colitis performed so far.

Press Release, 10th October 2005

Mutaflor® Suspension: New Standard in Diarrhea

Gain in time of up to 3.3 days for infants and toddlers

Two new confirmative trials prove efficacy and tolerance of Escherichia coli strain Nissle 1917 in the treatment of infants and toddlers suffering from acute or prolonged diarrhea. The results surpass all data published to date on probiotics in similar indications with regard to the success rate and time to response. Read on...